Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Oral Communications
Home
Oral Communications
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Alzheimer
Oral Communications
24 October 2023
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
Concussions
Oral Communications
13 October 2023
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Alzheimer
Oral Communications
16 September 2021
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Photobiomodulation at the Level of Single Neural Cells in Culture
Alzheimer
Oral Communications
2 January 2021
Photobiomodulation at the Level of Single Neural Cells in Culture
Relevance of photobiomodulation technique in AD treatment
Alzheimer
Oral Communications
5 November 2020
Relevance of photobiomodulation technique in AD treatment
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
Alzheimer
Oral Communications
2 July 2019
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
Neuroprotective effect of novel photobiomodulation technology reduces microbiota dysbiosis in the Aβ25-35 mouse model
Alzheimer
Oral Communications
30 January 2019
Neuroprotective effect of novel photobiomodulation technology reduces microbiota dysbiosis in the Aβ25-35 mouse model
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
Alzheimer
Oral Communications
25 January 2019
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Alzheimer
Oral Communications
6 June 2018
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Get a Quote